Coronavirus pharma news roundup – 10/07/20
Virtual healthcare during pandemic has won patients over; survey
Safe-haven flows surge on rising coronavirus cases!
European Open – A Testing Day For Stocks
Summer statement: £2 billion scheme will not be enough to prevent mass youth unemployment
Blain: There's A "Massively Larger Problem" In UK Homeownership
UK Commits "Highway Robbery" Of Venezuelan Gold, Says Academic
Insilico Medicine and Arctoris to collaborate on COVID-19 by combining robotics and AI
My new life as a coronavirus tester – a scientist's story
GBP/USD up on mini-Budget, Brexit talks next
VanEck launches global ‘Wide Moat’ ETF in Europe
S&P Futures Flat As China's Bubblemania Storms Higher For 8th Day
US dollar dips lower
The Survival of Millions of Small Businesses Is Threatened
Aetion, Cegedim form transatlantic real-world data alliance
GBP jumps on UK chancellor’s mini-budget. What’s next?
People With Mild COVID-19 May Experience 'Serious' Brain Disorders: UK Neurologists
Neutralizing antibodies in the battle against COVID-19
US Update: Stocks higher on fiscal stimulus hopes, Sunak’s stimulus booster, Oil anchored, Gold roars, Brazil’s gloom
5 COVID-19 myths politicians have repeated that just aren't true
Heathrow ready to host UK’s first COVID-19 airport testing trial
Question marks for traders in uncertain forex environment
Mini-Budget delivered, but will it deliver?
Futures Drift As Gold Soars
Blain: "Pragmatism Is Out The Window, The Days Of Madness Are Upon Us"
Protecting cancer patients from COVID-19: World-first trial tests novel immune-booster
Coronavirus recovery – the new economic thinking we need
Why going camping could be the answer to your lockdown holiday woes
Futures Drifts As Gold Soars
Consolidation is the Flavor of the Day